Consumer Reports
Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?
Today at 2:00 p.m. EST
Donna Cooper holds up a dosage of Wegovy. (Amanda Andrade-Rhoades/AP)
Consumer Reports has no financial relationship with any advertisers on this site.
Are you wondering whether you’re a candidate for one of the newer weight-loss drugs, semaglutide (Wegovy) and tirzepatide (Zepbound)? These injectables are approved specifically for weight loss in adults who are overweight or have obesity plus at least one of these conditions: high blood pressure, Type 2 diabetes, or high cholesterol.